BACKGROUND: Concise, accurate measures of maternal prenatal alcohol use are needed to better understand fetal alcohol spectrum disorders (FASD). METHODS: Measures of drinking by mothers of children with specific FASD diagnoses and mothers of randomly-selected controls are compared and also correlated with physical and cognitive/behavioral outcomes. RESULTS: Measures of maternal alcohol use can differentiate maternal drinking associated with FASD from that of controls and some from mothers of alcohol-exposed normals. Six variables that combine quantity and frequency concepts distinguish mothers of FASD children from normal controls. Alcohol use variables, when applied to each trimester and three months prior to pregnancy, provide insight on critical timing of exposure as well. Measures of drinking, especially bingeing, correlate significantly with increased child dysmorphology and negative cognitive/behavioral outcomes in children, especially low non-verbal IQ, poor attention, and behavioral problems. Logistic regression links (p<.001) first trimester drinking (vs. no drinking) with FASD, elevating FASD likelihood 12 times; first and second trimester drinking increases FASD outcomes 61 times; and drinking in all trimesters 65 times. Conversely, a similar regression (p=.008) indicates that drinking only in the first trimester makes the birth of a child with an FASD 5 times less likely than drinking in all trimesters. CONCLUSIONS: There is significant variation in alcohol consumption both within and between diagnostic groupings of mothers bearing children diagnosed within the FASD continuum. Drinking measures are empirically identified and correlated with specific child outcomes. Alcohol use, especially heavy use, should be avoided throughout pregnancy.
BACKGROUND: Concise, accurate measures of maternal prenatal alcohol use are needed to better understand fetal alcohol spectrum disorders (FASD). METHODS: Measures of drinking by mothers of children with specific FASD diagnoses and mothers of randomly-selected controls are compared and also correlated with physical and cognitive/behavioral outcomes. RESULTS: Measures of maternal alcohol use can differentiate maternal drinking associated with FASD from that of controls and some from mothers of alcohol-exposed normals. Six variables that combine quantity and frequency concepts distinguish mothers of FASD children from normal controls. Alcohol use variables, when applied to each trimester and three months prior to pregnancy, provide insight on critical timing of exposure as well. Measures of drinking, especially bingeing, correlate significantly with increased child dysmorphology and negative cognitive/behavioral outcomes in children, especially low non-verbal IQ, poor attention, and behavioral problems. Logistic regression links (p<.001) first trimester drinking (vs. no drinking) with FASD, elevating FASD likelihood 12 times; first and second trimester drinking increases FASD outcomes 61 times; and drinking in all trimesters 65 times. Conversely, a similar regression (p=.008) indicates that drinking only in the first trimester makes the birth of a child with an FASD 5 times less likely than drinking in all trimesters. CONCLUSIONS: There is significant variation in alcohol consumption both within and between diagnostic groupings of mothers bearing children diagnosed within the FASD continuum. Drinking measures are empirically identified and correlated with specific child outcomes. Alcohol use, especially heavy use, should be avoided throughout pregnancy.
Authors: Philip A May; Barbara G Tabachnick; J Phillip Gossage; Wendy O Kalberg; Anna-Susan Marais; Luther K Robinson; Melanie Manning; David Buckley; H Eugene Hoyme Journal: Drug Alcohol Depend Date: 2011-06-11 Impact factor: 4.492
Authors: Matthew Valentine; Dustin C J Bihm; Lior Wolf; H Eugene Hoyme; Philip A May; David Buckley; Wendy Kalberg; Omar A Abdul-Rahman Journal: Pediatrics Date: 2017-12 Impact factor: 7.124
Authors: Philip A May; Kari J Hamrick; Karen D Corbin; Julie M Hasken; Anna-Susan Marais; Lesley E Brooke; Jason Blankenship; H Eugene Hoyme; J Phillip Gossage Journal: Reprod Toxicol Date: 2014-02-22 Impact factor: 3.143
Authors: Philip A May; Anna-Susan Marais; Marlene M de Vries; Wendy O Kalberg; David Buckley; Julie M Hasken; Colleen M Adnams; Ronel Barnard; Belinda Joubert; Marise Cloete; Barbara Tabachnick; Luther K Robinson; Melanie A Manning; Kenneth Lyons Jones; Heidre Bezuidenhout; Soraya Seedat; Charles D H Parry; H Eugene Hoyme Journal: Drug Alcohol Depend Date: 2016-10-06 Impact factor: 4.492
Authors: Vikas N Kodali; Joseph L Jacobson; Nadine M Lindinger; Neil C Dodge; Christopher D Molteno; Ernesta M Meintjes; Sandra W Jacobson Journal: Alcohol Clin Exp Res Date: 2017-01-11 Impact factor: 3.455
Authors: Mary J O'Connor; Larissa C Portnoff; Michael Lebsack-Coleman; Katrina M Dipple Journal: Birth Defects Res Date: 2019-01-24 Impact factor: 2.344
Authors: H Eugene Hoyme; Wendy O Kalberg; Amy J Elliott; Jason Blankenship; David Buckley; Anna-Susan Marais; Melanie A Manning; Luther K Robinson; Margaret P Adam; Omar Abdul-Rahman; Tamison Jewett; Claire D Coles; Christina Chambers; Kenneth L Jones; Colleen M Adnams; Prachi E Shah; Edward P Riley; Michael E Charness; Kenneth R Warren; Philip A May Journal: Pediatrics Date: 2016-07-27 Impact factor: 7.124